About 13% of Europeans Vaccinated Against COVID-19

The European Center for Disease Prevention and Control (ECDC) announced on May 12, 2021, key figures on the COVID-19 vaccine rollout in the EU/EEA as of week #18 (May 9, 2021).

These highlights include, but are not limited to the following:

• The total number of vaccine doses distributed by manufacturers to EU/EEA countries: 209,090,038 (29 countries reporting).
• Cumulative uptake of full vaccination among adults aged 18 years and above: median of 13.3% (30 countries reporting).
• This graph shows the cumulative number of full vaccinations among adults (aged 18 years and above) in EU/EEA countries as a percentage over the country population aged 18 years and above.

As of May 13, 2021, the European Medicines Agency had authorized four COVID-19 vaccines for use in the EU, which are: Comirnaty (BioNTech-Pfizer), COVID-19 Vaccine Moderna, Vaxzevria (previously AstraZeneca), and J&J's COVID-19 Vaccine Janssen.

About (99) COVID-19 vaccine candidates are undergoing clinical trials and 184 pre-clinical vaccines are in development, reported GAVI.org on May 12, 2021.

The data presented in this ECDC report are collected through The European Surveillance System.